Bortezomib Consolidation Trial
NCT01517724
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Bortezomib
Sponsor
University College, London